OLGAX
Price
$85.60
Change
-$0.12 (-0.14%)
Updated
Sep 5 closing price
Net Assets
119.19B
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
331.65B
Interact to see
Advertisement

OLGAX vs RGEBX

Header iconOLGAX vs RGEBX Comparison
Open Charts OLGAX vs RGEBXBanner chart's image
JPMorgan Large Cap Growth A
Price$85.60
Change-$0.12 (-0.14%)
VolumeN/A
Net Assets119.19B
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets331.65B
OLGAX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
OLGAX vs. RGEBX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OLGAX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. OLGAX (119B). OLGAX (0.00) and RGEBX (0.00) have matching dividends . OLGAX was incepted earlier than RGEBX: OLGAX (32 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than OLGAX (1.00). OLGAX is a more actively managed with annual turnover of: 32.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than OLGAX: RGEBX (250) vs OLGAX (1000). OLGAX annual gain was more profitable for investors over the last year : 22.32 vs. RGEBX (17.32). OLGAX return over 5 years is better than : 55.04 vs. RGEBX (38.39).
OLGAXRGEBXOLGAX / RGEBX
Total Expense Ratio0.941.0986%
Annual Report Gross Expense Ratio1.001.0992%
Fund Existence32 years11 years-
Gain YTD10.80715.13271%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets119B332B36%
Annual Yield % from dividends0.000.00-
Returns for 1 year22.3217.32129%
Returns for 3 years84.8657.24148%
Returns for 5 years55.0438.39143%
Returns for 10 years136.3491.00150%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
ARCT17.851.09
+6.50%
Arcturus Therapeutics Holdings
MANH215.315.45
+2.60%
Manhattan Associates
TRMD23.020.25
+1.10%
TORM plc
INDP3.30-1.31
-28.35%
Indaptus Therapeutics Inc